Spearhead Capital Advisors, LLC Neogenomics Inc Transaction History

Spearhead Capital Advisors, LLC

  • $92.3 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021
SELL
$41.56 - $59.88 $316,022 - $455,327
-7,604 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$36.08 - $56.47 $40,698 - $63,698
-1,128 Reduced 12.92%
7,604 $409,000
Q3 2020

Oct 16, 2020
BUY
$33.26 - $40.48 $60,300 - $73,390
1,813 Added 26.2%
8,732 $322,000
Q2 2020

Jul 16, 2020
BUY
$24.21 - $31.02 $167,508 - $214,627
6,919 New
6,919 $214,000

Others Institutions Holding NEO

# of Institutions
292
Shares Held
124M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.34B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Spearhead Capital Advisors, LLC Portfolio

Follow Spearhead Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email